All the news Showing 10 of 217 articles from: Pharmaceutical industryGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Gilead to launch generic versions of its hepatitis drugs Reuters / 25 September 2018 What It Means for Gilead to Launch Its Own Generics for Hepatitis C Treatments 24/7 Wall St. / 25 September 2018 EPO Upholds Gilead Patent On Hep C Medicines, But In Amended Form Intellectual Property Watch / 16 September 2018 Merck’s 60% price cut for hepatitis C drug nets company a big sales opportunity Market Watch / 08 August 2018 Merck To Steeply Cut Price of Hepatitis C Drug Zepatier Managed Care Magazine / 22 July 2018 How Big Pharma Was Captured by the One Percent New Republic / 02 July 2018 Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents Intellectual Property Watch / 14 May 2018 Gilead Topples As Its Hepatitis C Drug Franchise Continues To Crumble Investor's Business Daily / 02 May 2018 Pharmaceutical companies and non-profits team up to provide affordable hepatitis C treatment in Latin America Drugs for Neglected Diseases initiative / 06 March 2018 Gilead wins reversal of $2.54 bln hepatitis C drug patent verdict Nasdaq / 19 February 2018 ← Prev1...23456...22Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Noticeboard Email bulletins News feeds